SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Block listing update

8 Oct 2019 10:00

RNS Number : 1338P
Porvair PLC
08 October 2019
Β 

8 October 2019

Β 

Porvair plc

("Porvair" or the "Group")

Β 

Block listing update

Β 

Porvair, the specialist filtration and environmental technologies group, announces that an application has been made to the Financial Conduct Authority ("FCA") and London Stock Exchange ("LSE") in order to increase an existing block listing of ordinary shares of 2 pence per share ("Ordinary Shares") used to satisfy the issue of shares pursuant to exercises of options under the Porvair plc SAYE Share Option Plan 2014 ("SAYE Plan").

Β 

Application has been made for the admission of 510,269 new Ordinary Shares to the premium listing segment of the Official List of the FCA and to trading on the main market of the LSE (together "Admission"). New Ordinary Shares issued under the block listing will rank pari passu in all respect with the existing Ordinary Shares of the Company. It is expected that Admission will become effective on 10 October 2019.

Β 

In addition, the Company currently has 21,925 new Ordinary Shares admitted (but not yet issued) under an existing block listing that relate to the Porvair Long Term Share Plan 2008 (the "LTSP"). All share issues expected to be required in order to satisfy the exercise of options under the LTSP have been made and, as a result, the associated LTSP block listing will be cancelled. The Company made 151,375 allotments under the LTSP since the last block listing return. The block listing return, as at 7 October 2019 is set out below.

Β 

The Company's issued share capital will not change as a result of the changes to the block listings set out above.

Β 

Total Voting Rights

The Company's issued share capital consists of 45,843,599 Ordinary Shares with voting rights. Therefore, the total number of voting rights in the Company will be 45,843,599. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the disclosure guidance issued by the FCA and the transparency rules made by the FCA under section 89A(1) of the Financial Services and Markets Act 2000, as amended.

Β 

For more information, contact:

Β 

Porvair plc

Β 

Ben Stocks, Chief Executive

01553 765 500

Chris Tyler, Group Finance Director

01553 765 500

Β 

Β 

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

Β 

Β 

Β 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

Β 

Β 

Name of applicant:

Porvair plc

Name of scheme:

Porvair Long Term Share Plan 2008

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

173,300

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(151,375)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

21,925

Β 

Name of applicant:

Porvair plc

Name of scheme:

Porvair plc SAYE Share Option Plan 2014

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

129,561

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

510,269

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(51,049)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

588,781

Β 

Β 

Name of contact:

Chris Tyler (Group Finance Director)

Telephone number of contact:

01553 765 500

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
ALSUWVWRKNARRRA
Date   Source Headline
11th Nov 20201:17 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSDirectorate Change
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSNine months trading update
18th Sep 20203:58 pmRNSChange of auditor
2nd Sep 20202:09 pmRNSHolding(s) in Company
19th Aug 20204:03 pmRNSDirector/PDMR Shareholding
10th Aug 20204:40 pmRNSSecond Price Monitoring Extn
10th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20207:00 amRNSTotal Voting Rights
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSHalf Year Results 2020
25th Jun 20204:52 pmRNSDirector/PDMR Shareholding
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
19th May 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20209:27 amRNSPublication of Articles of Association
21st Apr 20201:59 pmRNSAGM resolutions and Board changes
8th Apr 20204:03 pmRNSBlock listing six monthly return
8th Apr 20207:00 amRNSTrading Update and Covid-19 Statement
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAnnual General Meeting 2020 – Change of Venue
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202010:20 amRNSHolding(s) in Company
18th Feb 202012:07 pmRNSSecond Price Monitoring Extn
18th Feb 202012:02 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20203:15 pmRNSPDMR Shareholding Grant of Options
3rd Feb 20207:00 amRNSPreliminary Results and Board Changes
18th Dec 20195:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.